DABIGEN 150
DABIGEN 150 contains Dabigatran Etexilate 150 mg, an oral anticoagulant used to prevent and treat blood clots. It works by directly inhibiting thrombin, reducing the formation of harmful clots. It is commonly prescribed in conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Regular use helps lower the risk of stroke and supports safe, long-term blood thinning when taken under medical supervision.
Related products
TELLME TRIO CC
TELLME CC combines Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg. This...
TELLME 40 CT 6.25
TELLME 40 CT 6.25 includes Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 6.25...
TELLME H
TELLME H is a combination of Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg. Telmisartan relaxes...
